Caricamento...
Emerging drugs for myelofibrosis
INTRODUCTION: Myelofibrosis (MF), a Philadelphia chromosome-negative myeloproliferative neoplasm, is a life-threatening heterogeneous disorder characterized by dysregulation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling network. The clinical hallmarks of...
Salvato in:
| Pubblicato in: | Expert Opin Emerg Drugs |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2012
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5009610/ https://ncbi.nlm.nih.gov/pubmed/23186315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728214.2012.748748 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|